Gene · 7329
Papers3,237
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,237
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hepatitis Delta Virus-Host Protein Interactions: From Entry to Egress. | Viruses | 2023 | 37515216 | PubTator, text mining | PubMed |
| Targeting Inflammasome Activation in Viral Infection: A Therapeutic Solution? | Viruses | 2023 | 37515138 | PubTator, text mining | PubMed |
| Approach to Functions of BHLHE41/DEC2 in Non-Small Lung Cancer Development. | Int J Mol Sci | 2023 | 37511489 | PubTator, text mining | PubMed |
| Transposable Elements: Epigenetic Silencing Mechanisms or Modulating Tools for Vertebrate Adaptations? Two Sides of the Same Coin. | Int J Mol Sci | 2023 | 37511347 | PubTator, text mining | PubMed |
| A comprehensive protein interaction map and druggability investigation prioritized dengue virus NS1 protein as promising therapeutic candidate. | PLoS One | 2023 | 37498862 | PubTator, text mining | PubMed |
| Cardio-oncology: Shared Genetic, Metabolic, and Pharmacologic Mechanism. | Curr Cardiol Rep | 2023 | 37493874 | PubTator, text mining | PubMed |
| Multilevel regulation of N6-methyladenosine RNA modifications: Implications in tumorigenesis and therapeutic opportunities. | Genes Dis | 2023 | 37492716 | PubTator, text mining | PubMed |
| Actionable loss of SLF2 drives B-cell lymphomagenesis and impairs the DNA damage response. | EMBO Mol Med | 2023 | 37485814 | PubTator, text mining | PubMed |
| The SUMO-NIP45 pathway processes toxic DNA catenanes to prevent mitotic failure. | Nat Struct Mol Biol | 2023 | 37474739 | PubTator, text mining | PubMed |
| DeSUMOylation of chromatin-bound proteins limits the rapid transcriptional reprogramming induced by daunorubicin in acute myeloid leukemias. | Nucleic Acids Res | 2023 | 37462077 | PubTator, text mining | PubMed |
| Deubiquitinase USP9X stabilizes RNA m6A demethylase ALKBH5 and promotes acute myeloid leukemia cell survival. | J Biol Chem | 2023 | 37454738 | PubTator, text mining | PubMed |
| Loss of PML nuclear bodies in familial amyotrophic lateral sclerosis-frontotemporal dementia. | Cell Death Discov | 2023 | 37454169 | PubTator, text mining | PubMed |
| The SUMO-interacting motif in NS2 promotes adaptation of avian influenza virus to mammals. | Sci Adv | 2023 | 37436988 | PubTator, text mining | PubMed |
| Identification of key genes and the pathophysiology associated with allergen-specific immunotherapy for allergic rhinitis. | BMC Immunol | 2023 | 37430199 | PubTator, text mining | PubMed |
| The emerging roles of SUMOylation in the tumor microenvironment and therapeutic implications. | Exp Hematol Oncol | 2023 | 37415251 | PubTator, text mining | PubMed |
| Changes in SUMO-modified proteins in Epstein-Barr virus infection identifies reciprocal regulation of TRIM24/28/33 complexes and the lytic switch BZLF1. | PLoS Pathog | 2023 | 37410772 | PubTator, text mining | PubMed |
| Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer's disease. | Sci Transl Med | 2023 | 37406134 | PubTator, text mining | PubMed |
| SUMOylation of Rho-associated protein kinase 2 induces goblet cell metaplasia in allergic airways. | Nat Commun | 2023 | 37393345 | PubTator, text mining | PubMed |
| Epigenetic modification of m6A regulator proteins in cancer. | Mol Cancer | 2023 | 37391814 | PubTator, text mining | PubMed |
| A novel approach for the analysis of single-cell RNA sequencing identifies TMEM14B as a novel poor prognostic marker in hepatocellular carcinoma. | Sci Rep | 2023 | 37380717 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7329/papers?page=12